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AT-1015, a novel serotonin2A receptor antagonist,
improves resaturation of exercised ischemic muscle
in hypercholesterolemic rabbits
Takashi Komiyama, MD, Hideaki Kihara, Ken Hirose, Ryota Yoshimoto, PhD, and Hiroshi Shigematsu,
MD, Tokyo, Japan
Objective: The effect of AT-1015, a serotonin2A receptor antagonist, on the resaturation of ischemic muscle in a
hypercholesterolemic rabbit model was examined with near-infrared spectroscopy.
Methods: New Zealand White male rabbits were fed normal chow or cholesterol-rich chow. Ischemia was induced in the
right hindlimb by ligation of the femoral artery, accompanied by balloon injury of the iliac artery. At 3 days after
induction of ischemia, the bilateral gastrocnemius muscles were subjected to passive contraction for 2 minutes. The
oxygen resaturation time of the gastrocnemius muscle after exercise was measured by near-infrared spectroscopy.
AT-1015 was orally administered for 3 days after induction of ischemia. Assay of serotonin level in platelet-poor plasma
and histologic examination of muscle and artery were performed in another set of rabbits.
Results: Oxygen resaturation time of the ischemic gastrocnemius was significantly prolonged in hypercholesterolemic
rabbits compared with in normal rabbits without AT-1015, whereas there was no difference between both groups of
rabbits that were administered AT-1015. Plasma level of serotonin in hypercholesterolemic rabbits was significantly
increased compared with that in normal rabbits. No histologic differences were found in both muscle and artery among
all groups.
Conclusions: A serotonin2A receptor antagonist improved the oxygen resaturation of ischemic calf muscle after exercise in
hypercholesterolemia. The interaction between plasma free serotonin and the serotonin2A receptor may play an important
role in muscle oxygenation in ischemic limbs. (J Vasc Surg 2004;39:661-7.)
Platelet aggregation and activation at the damaged
endothelium in arteries are considered to play an important
role in the local oxygenation of peripheral tissue.1 It has
been demonstrated that serotonin (5-hydroxytryptamine,
5HT), a vasoactive substance derived from activated plate-
lets, is released into the coronary circulation after percuta-
neous coronary angioplasty and that it contributes to the
occurrence of vasoconstriction distal to the dilated site.2
Furthermore, 5HT has oversensitive vasoconstrictive ef-
fects on collateral vessels in comparison with normal ves-
sels, and this effect is mediated by the 5HT2 receptor.
3,4
5HT is also reported to have a mitogenic effect on damaged
arteries, which was potentiated by lipoproteins from hyper-
cholesterolemic plasma.5 However, the vasoconstrictive ef-
fects of 5HT on ischemic skeletal muscle during exercise
have yet to be revealed because of lack of an appropriate
model as well as of accurate parameters to directly assess the
exercising muscle oxygenation. Therefore, the efficacy of a
5HT receptor antagonist on exercising ischemic muscle has
not yet been confirmed.
Near-infrared spectroscopy (NIRS) is a new technique
for evaluating tissue oxygenation directly and noninva-
sively. Our group and others reported elsewhere that NIRS
can accurately assess the severity of ischemia of exercising
muscle in patients with peripheral vascular disease.6-8 We
also reported recently that the decrease in muscle oxygen
saturation during exercise correlated well with the severity
of symptoms of intermittent claudication.9
The aim of this study was to evaluate the effect of
AT-1015, a novel 5HT2A receptor antagonist, on the oxy-






amide monohydrochloride monohydrate, is a novel 5HT2A
receptor antagonist, synthesized by Ajinomoto Co. (Ka-
wasaki, Japan).
Animal model
This study was performed according to a protocol
approved by the Institutional Animal Care and Use Com-
mittee of the Faculty of Medicine, the University of Tokyo,
and the Pharmaceutical Research Laboratories of Ajino-
moto Co. The investigation conformed with the Guide for
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the Care and Use of Laboratory Animals published by the
US National Institute of Health (NIH publication 85-23,
revised 1996). All surgical procedures were performed un-
der sterile conditions.
Ischemia was induced in the right hindlimb of all
rabbits under anesthesia with an intramuscular injection of
a mixture of ketamine (60 mg/kg) and xylazine (5 mg/
kg). After incision of the skin, the femoral artery was
exposed, and a sterile 3 Fr Fogarty balloon catheter (Baxter
Healthcare Co.) was inserted into the right femoral artery
and advanced 7 cm into the right iliac artery. Balloon injury
was accomplished by three passes of a balloon that was
inflated to a diameter of 5 mm with 50 L of water. After
balloon injury, the femoral artery was ligated with double
silk ligatures (3-0). After application of 1 mL of an anti-
infection spray containing 0.5% kanamycin sulfate (Meiji
Seika Co., Tokyo, Japan) to the wound, the incision was
carefully sutured to prevent self-mutilation by animals.
After the surgical procedure, the animals were housed
individually in a temperature-controlled room with a 12-
hour light-dark cycle, with free access to water and freedom
of movement.
Experimental groups
Forty-two male New Zealand White rabbits (Tokyo
Laboratory Animals Science Co., Ltd.) were studied.
Groups fed regular chow. Twenty-three rabbits were
fed regular rabbit chow (RC4, Oriental Yeast Co., Tokyo,
Japan) ad libitum for 1 week from 12 weeks after birth.
These rabbits were divided into two groups: the control
group rabbits received distilled water alone (n  11). Five
were subjected to laboratory assay of a blood sample. The
plasma concentration of total cholesterol was 27  15
mg/dL. The other six rabbits were subjected to NIRS
measurement. The AT-1015 group rabbits received AT-
1015 (3 mg/kg) dissolved in distilled water (2 mL/kg)
orally, once a day for 3 days, from the day after induction of
ischemia to the day of NIRS measurement (n  7).
Groups fed cholesterol-enriched chow. Twenty-
four rabbits were fed cholesterol-enriched chow (RC4 con-
taining 1% cholesterol; Oriental Yeast Co.), at 100 g per
animal, each day for 5 weeks from 8 weeks after birth. These
rabbits were divided into two groups with similar baseline
values of plasma cholesterol and body weight, to receive
AT-1015 or distilled water. The cholesterol group rabbits
received distilled water alone (n 15). Eight of these were
subjected to laboratory assay of a blood sample; the plasma
concentration of total cholesterol was 1464 352 mg/dL.
The other seven rabbits were subjected to NIRS measure-
ment. The cholesterolAT-1015 group rabbits received AT-
1015 and were subjected to NIRS measurement (n  9).
Measurement of muscle oxygen saturation by NIRS
At 3 days after induction of ischemia, oxygen saturation
of the gastrocnemius muscle was measured by NIRS. AT-
1015 or distilled water was administered 2 hours before
NIRS measurement. Under the same anesthesia as for the
previous induction of ischemia, each animal was fixed to a
wooden stand in a supine position on a warmed sheet at
40°°C (Pharmaseal, Baxter Healthcare Corporation, Va-
lencia, CA), to maintain a constant body temperature.
Throughout the experiment, the room temperature was
kept at 24°-26°C. An incision was made in the calf skin and
the fascia over both medial heads of the gastrocnemius. The
light guide and detector of a near-infrared spectrophotom-
eter (MCPD-2000; Otsuka Electronics, Osaka, Japan)
were applied directly on the surface of the medial head of
the gastrocnemius. The optodes were fastened on the mus-
cle by the skin closure without any invasion of the muscle
tissue. The distance between the light guide and the detec-
tor was 5 mm. The electrodes of an electrical stimulator
(SEN-3301; Nihon Kohden Co, Tokyo, Japan) were
placed on the bilateral ischial nerves through incisions in
the lateral upper thigh.
Then the rabbit was placed in the supine position with
the head suspended 23 cm above the calf. After 5 minutes
of baseline observation, the bilateral gastrocnemius muscles
received passive contraction by 1-Hz stimulation of the
bilateral ischial nerves for 2 minutes. Muscle oxygen satu-
ration was measured continuously during all periods, and
the half-resaturation time of the gastrocnemius after stim-
ulation was also determined to assess the oxygenation of
the gastrocnemius in both the ischemic and intact legs. The
validity of measurement of half-recovery time with NIRS
was previously reported.10
The design and features of the MCPD-2000 have been
described elsewhere.11,12 This spectrophotometer mea-
sured the continuous wave spectrum of the muscle at every
2 nm from 700 to 1000 nm. The sampling time of each
scan was 0.6 seconds, and measurement of muscle oxygen
saturation was performed every 5 seconds. After correcting
the deformation of the absorption spectrum caused by
scattering, quantification of oxygenated hemoglobin
(HbO2) and deoxygenated hemoglobin (HHb) was per-
formed by multicomponent curve-fitting analysis. Muscle
oxygen saturation was calculated with the following for-
mula:
Muscle oxygen saturation  HbO2/(HbO2  HHb)
Hemodynamic measurements
Through NIRS measurement, brachial blood pressure
and pulse rate were continuously monitored on a pen
recorder (WT-687G; Nihon Koden Co., Tokyo, Japan) by
means of a polyethylene tube that was inserted via the right
brachial artery.
Laboratory assay of blood sample
At 3 days after intervention, a blood sample was exam-
ined in both the control and the cholesterol groups. All
animals underwent laparotomy under the same anesthesia
as specified above. A 10-mL sample of blood from the
inferior vena cava was withdrawn into a plastic syringe with
a 18-G needle. Then, platelet-poor plasma (PPP) was ob-
tained according to a method reported elsewhere.13 The
concentrations of plasma 5-HT, -thrombogloblin, plate-
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let factor 4, thromboxane B2, and 6-keto-prostaglandin
F1 (PGF1) in PPP were examined. Total cholesterol,
number of platelets, and concentration of whole-blood
5-HT were also determined.
Histologic assays
Another set of 24 rabbits (n  6 in each group) was
killed for histologic examination of muscle and artery at 3
days after induction of ischemia. According to a previous
report,14 the capillary density (capillaries per square milli-
meter) of the gastrocnemius muscle from both ischemic
and intact legs was determined. Muscle wet weight to body
weight ratio was also determined. Regarding the artery, the
degree of stenosis was calculated as the ratio of the area of
intimal hyperplasia to the area of lumen and intimal hyper-
plasia stained with elastic van Gieson.
Reproducibility of NIRS measurements
Another set of control rabbits (n  5) underwent
repeated measurements of muscle oxygen saturation to
determine the reproducibility of NIRS measurements at 3
days after induction of ischemia. The interval between the
first and second measurement was 30 minutes. Muscle
oxygen saturation at rest and at the end of exercise were
assessed. The half-resaturation time of the gastrocnemius
was also determined. The reproducibility of NIRS measure-
ments was analyzed by means of the intraclass correlation
coefficient.15 Almost perfect agreement was found for all
repeated measurements of muscle oxygen saturation at rest
and after exercise. Substantial agreement was found in the
measurements of the half-resaturation time of the gastroc-
nemius in the ischemic leg, whereas only good agreement
was found in the intact leg (Table I).
Statistical analysis
All results are presented as mean  standard deviation.
Comparisons between two unpaired means were per-
formed by Mann-Whitney U test. Comparisons between
two paired means were performed by Wilcoxon rank test.
For intergroup comparisons, one-way ANOVA followed
by Scheffe’s F test was used. A probability of P  .05 was
considered statistically significant.
RESULTS
No rabbits from the four groups developed distal limb
necrosis of the ischemic limb. At the time of NIRS mea-
surement, body weight of the controls (3.3  0.2 kg) and
the AT-1015 group (3.1 0.1 kg) was significantly heavier
than that of the cholesterol group (2.5  0.2 kg) and the
cholesterolAT-1015 group (2.4  0.1 kg; P  .0001),
whereas there were no differences between the same diet
groups.
Muscle oxygen saturation measurement by NIRS.
Figure 1 shows all results of muscle oxygen saturation
measurements. A significant difference among groups was
only found in the ischemic legs between the controls and
cholesterolAT-1015 group (P  .018). A significant
decrease of muscle oxygen saturation at the end of exercise
compared with at rest was found in controls (P .046) and
the AT-1015 group (P  .018) in intact legs, and in
controls (P  .028), AT-1015 (P  .018), and
cholesterolAT-1015 (P  .021) groups in ischemic legs.
A significant increase in muscle oxygen saturation in isch-
emic legs, compared with in intact legs, was found in
controls at rest (P  .046) and in the cholesterolAT-
1015 group at the end of exercise (P  .028).
The half-resaturation time of the ischemic gastrocne-
mius muscle after exercise was significantly shortened in the
cholesterolAT-1015 group compared with that in the
cholesterol group (P  .034), whereas there was no differ-
ence between the AT-1015 group and the controls (P 
.81). It was significantly prolonged in the cholesterol group
compared with that in the controls (P .038; Fig 2). There
were no significant differences in the half-resaturation time
of the intact gastrocnemius among all groups (control:
0.26  0.13, AT-1015: 0.18  0.12, cholesterol: 0.26 
0.17, cholesterolAT-1015: 0.22  0.14; P  .64).
Hemodynamic measurements. In the other hemo-
dynamic parameters, brachial systolic blood pressure at rest
and at the end of exercise and pulse rate at rest and at the
end of exercise, there were no significant differences among
all groups.
Biochemical measurements. Laboratory data are
shown in Table II. The plasma concentration of total
cholesterol was significantly higher in the cholesterol group
than in the controls, whereas there was no significant
difference in number of platelets between the two groups.
In the cholesterol group, 5-HT in PPP was significantly
higher, and 5-HT in whole blood was significantly lower,
than in the controls. The concentration of TXB2 in PPP was
significantly higher in the cholesterol group than in the
controls, whereas PGF1 was not significantly different
between the two groups. -thrombogloblin and platelet
factor 4 are not shown in Table II because their values were
below the detection limit in almost all animals.
Table I. Reproducibility of muscle oxygen saturation












First 83  9 63  6 1.51  0.51
Second 80  8 65  8 1.66  0.90
rI* 0.86 0.89 0.76
Intact leg
First 93  9 81  7 0.18  0.05
Second 89  9 81  6 0.13  0.05
rI* 0.93 0.85 0.47
*According to rI value, agreement was considered almost perfect (rI 0.81),
substantial (0.80  rI  0.61), good (0.60  rI  0.41), fair (0.40  rI 
0.21), or slight (rI  0.20).16
SmO2 , Muscle oxygen saturation; r1, intraclass correlation coefficient be-
tween first and second measurement.
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 3 Komiyama et al 663
Histologic assays. Capillary density (cap/mm2) was
not significantly different both in intact legs (control: 282
 30, AT-1015: 311  26, cholesterol: 288  20,
cholesterolAT-1015: 344  23) (P  .32) and ischemic
legs (control: 245  13, AT-1015: 295  45, cholesterol:
294  16, cholesterolAT-1015: 313  15; P  .31)
among all groups, or between the intact and ischemic legs
in each group. Muscle weight to body weight ratio also
showed no significant differences among all groups, or
between the legs in each group. Regarding the artery, we
could not calculate the ratio because no detectable intimal
hyperplasia was shown in all animals from all groups.
DISCUSSION
We demonstrated in this study that hypercholesterol-
emia impairs the oxygenation of ischemic skeletal muscle
after exercise. Previous studies have demonstrated that
hypercholesterolemia induces hyperreactivity of platelets
from humans17 and rabbits.18 We found higher concentra-
tions of 5HT and TXB2 in PPP and a lower concentration
of 5HT in whole blood in hypercholesterolemic rabbits
compared with controls. These findings are similar to pre-
vious observations that platelet 5HT content was reduced
in hypercholeresterolemic humans19 and rabbits,20 because
Fig 1. Measurement of muscle oxygen saturation: A, intact legs; B, ischemic legs. The presented values at rest and at
the end of exercise were the averages of 30 seconds before electrical stimulation and 30 seconds before the end of
electrical stimulation, respectively. Bar represents 1 SD. *P .05 ischemic leg versus intact leg. †P .05 at rest versus
at end of exercise. ‡P  .05 versus control.
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almost all 5HT exists in platelets. The combined action of
5HT and thromboxane might enhance collateral spasm in
our model.21 Moreover, hypercholesterolemia impairs
5HT-induced vasodilatation, which is mediated by NO.22
Our result, that a 5HT2A receptor antagonist improved
muscle oxygenation during and after exercise in hypercho-
lesterolemia to the level of the controls, is strengthened by
the previous finding that 5HT dominates thromboxane A2
in reducing collateral blood flow.4
Regarding the agent, AT-1015, it has been demon-
strated elsewhere that AT-1015 has a blocking effect on
5HT2A receptor-mediated platelet aggregation and vaso-
constriction in various in vitro and ex vivo experiments in
rats.23 It also has been demonstrated that AT-1015 did not
affect cholesterol level in a 12-week rabbit model (unpub-
lished data, 2001, H.K.). Regarding the dose of AT-1015
employed in this study, the inhibitory activity of oral ad-
ministration of AT-1015 on platelet aggregation induced
by 5HTADP in rabbits was previously evaluated. The
ED50 value was 0.6 mg/kg, and the inhibition ratio of 3
mg/kg, which was the dose in this study, was 70%
(unpublished data). Because the activity of this dose in
rabbits was almost the same as that in rats,23 this particular
dose was selected.
Regarding the experimental model of limb ischemia,
the severity of muscle ischemia in our model is moderate
compared with other models.24,25 Indeed, we found no
difference in muscle oxygen saturation at rest between the
ischemic and intact legs. This finding is similar to our
previous results on human muscle saturation at rest.9 The
negative histological findings of muscle and artery also
support that our ischemic procedure did not alter the
substantial structure of skeletal muscles or arteries, but
affected the muscle oxygenation functionally.
Because the characteristics of atherosclerotic diseases
consist not only of arterial occlusion, but also of platelet
Fig 2. Half-resaturation time of gastrocnemius muscle in ischemic legs after exercise. Bar represents 1 SD. *P  .05
versus control, AT-1015, and cholesterolAT-1015. It was significantly prolonged in the cholesterol group compared
with that in the other groups. There were no significant differences in the intact legs among all groups. There were
distinct differences in the half-resaturation time of the gastrocnemius muscle between ischemic and intact legs in all
groups.












Control (n  5) 6.3  1.9 6.9  1.3 814  324 58  15 40.9  4.8
Cholesterol (n  7) 19.8  5.1 3.8  1.3 846  536 112  38 33.1  7.1
P value .002 .027 .909 .014 .061
p5HT, Serotonin in platelet-poor plasma; w5HT, serotonin in whole blood; PGF1, 6-keto prostaglandin F1; TXB2, thromboxane B2; PLT, number of
platelets.
*-thrombogloblin and platelet factor 4 were omitted from the table because they were below the detection limit in almost all animals.
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activation caused by the persistent damage of endothelial
cells,26,27 we added balloon injury of the iliac artery in
addition to ligation of the common femoral artery to repro-
duce a similar hyperactive condition of platelets that is
concomitant with arterial occlusion in the experimental
model, despite the fact that our model was not a chronic
ischemia model. A similar rabbit model has been reported
previously by Hollenberg et al.21 to assess the influence of
5-HT and thromboxane on collateral arteries.
Regarding the intensity of exercise, we considered that
2-minute passive contraction was sufficient because the
muscle oxygen saturation decreased and reached a plateau
during stimulation. Moreover, the intensity was considered
to be relatively strong because a decrease of muscle oxygen
saturation was found not only in the ischemic legs, but also
in the intact legs. We found significant differences in muscle
oxygen saturation between at rest and at the end of exer-
cise, whereas other differences were not considered to be
physiologically significant.
Therefore, our model is considered to be a model of
functional limb ischemia rather than of absolute limb isch-
emia. Whereas functional ischemia is characterized by in-
sufficiency of oxygen delivery not at rest but during exer-
cise, there have been few reports directly assessing the tissue
oxygenation in the ischemic muscles during exercise, both
in experimental and clinical studies. Our results demon-
strated that muscle oxygen saturation measurement can
provide objective information regarding the effects of
drugs, such as antiplatelet agents, on ischemic muscle dur-
ing exercise.
Regarding the sample size, despite the lack of estab-
lished data of NIRS measurement in experimental models,
we considered it to be appropriate for assessment of the
drug effect because there were distinct differences in the
half-resaturation time of the gastrocnemius muscle be-
tween ischemic and intact legs in all groups.
In this study, we used NIRS to evaluate muscle oxy-
genation at rest and during exercise. The advantage of this
new method lies in its ability to assess regional tissue
oxygenation directly and noninvasively. Nuclear magnetic
resonance spectroscopy (MRS) is a noninvasive method for
evaluating tissue oxygenation.10 In recent reports of simul-
taneous measurements with NIRS and MRS, both of these
measurements provided the same information to evaluate
the recovery of muscle ischemia after mild exercise.28 Al-
though MRS is also useful for assessing skeletal muscle
ischemia during exercise, it has limited application because
of difficulty applying it to general exercise such as walking,
as well as its high cost.
We demonstrated that the reproducibility of NIRS
measurements is sufficient for oxygen saturation measure-
ment not only at rest but also during exercise. We also
found adequate reproducibility of the half-resaturation
time in ischemic muscle, but not in intact muscle. The poor
reproducibility in intact legs may be explained by a rela-
tively high measurement error because of too rapid recov-
ery compared with ischemic legs.
In conclusion, our results demonstrated that AT-1015,
a 5HT2A receptor antagonist, improved oxygenation in
ischemic muscle after exercise in a hypercholesterolemic
rabbit model. These findings also indicated the efficacy of
our model for assessing drug effects on ischemic muscle
during exercise.
The authors thank Masatake Katsu, MD, for his sup-
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